Abstract

ALFONSO-BALBUENA, Tamara  and  SERNA-CUELLAR, Alder Isaías Leonor. Clinical and demographic characteristics of patients with deep vein thrombosis in a referral hospital in Paraguay during the COVID-19 pandemic (2020-2023). Rev. cient. cienc. salud [online]. 2024, vol.6, e6152.  Epub Oct 30, 2024. ISSN 2664-2891.  https://doi.org/10.53732/rccsalud/2024.e6152.

Introduction. Venous thromboembolic disease, which includes deep vein thrombosis (DVT), is the third most common cardiovascular disease worldwide, with significant morbidity and mortality. Objective. To describe the clinical and demographic characteristics of patients with Deep Vein Thrombosis (DVT) admitted to a referral hospital in Paraguay during the COVID-19 pandemic (2020-2023). Materials and methods. Observational, descriptive, retrospective, cross-sectional study. 80 patients over 18 years of age with a confirmed diagnosis of DVT were included, selected by non-probabilistic sampling of consecutive cases. Demographic, clinical, and treatment data were collected from medical records. Results. The mean age was 52 ± 17 years, with a predominance of females (55%, 95% CI: 44-66%). COVID-19 disease was the most frequent underlying pathology (29%, 95% CI: 19-39%). According to the Wells scale, 62.5% (95% CI: 51-73%) presented moderate risk of DVT. Limb asymmetry (65%, 95% CI: 54-75%) and calf pain (61.25%, 95% CI: 50-72%) were the most frequent symptoms. 72.5% (95% CI: 62-82%) received low molecular weight heparin during hospitalization. Conclusion. DVT in this center predominantly affected middle-aged women, with COVID-19 as an emerging risk factor. These findings underline the need for active surveillance of DVT in patients with COVID-19 and suggest the importance of prevention and treatment strategies adapted to the pandemic context in Paraguay.

Keywords : deep vein thrombosis; COVID-19; anticoagulants; low molecular weight heparin; risk factors..

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )